missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Rat TIM-1/KIM-1/HAVCR Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 2 publications
Marque: R&D Systems MAB3689-100
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
TIM-1/KIM-1/HAVCR Monoclonal specifically detects TIM-1/KIM-1/HAVCR in Rat samples. It is validated for ELISA Capture (Matched Antibody Pair).
Spécification
| TIM-1/KIM-1/HAVCR | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| CD365, HAVCR1, HAVCR-1, HAVCRT cell immunoglobin domain and mucin domain protein 1, hepatitis A virus cellular receptor 1, Kidney injury molecule 1, KIM1, KIM-1, T-cell immunoglobulin and mucin domain-containing protein 1, TIM1, TIM-1TIM, TIM1TIMD-1, TIMD1T-cell membrane protein 1 | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 26762 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
| ELISA | |
| 511227 | |
| ELISA Capture (Matched Antibody Pair) 2-8 ug/mL | |
| O54947 | |
| HAVCR1 | |
| Mouse Myeloma cell line NS0-derived recombinant rat TIM-1/KIM-1/HAVCR Ser18-Val238 Accession # O54947 | |
| 100 μg | |
| Primary | |
| Detects rat TIM-1/KIM-1/HAVCR in ELISAs. In sandwich immunoassays, no cross-reactivity or interference with recombinant mouse (rm) TIM-1, rmTIM-3, rmTIM-4, recombinant human (rh) TIM-1, rhTIM-4, or rhNKp44 is observed. | |
| Rat | |
| Supernatant |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu